Page 51 - Jurnal Farmasi Klinik Vol 4 No 1

Jurnal Farmasi Klinik Best Practice Volume 4 No 1

56. Frangou EA, Bertsias G.

Boumpas DT. Cytotoxic-

immunosupresive drug treatment.
In: Tsokos GC, editor: Systemic

lupus erythematosus: basic,
applied and clinical aspects.

Oxford: Elsevier, 2016. P. 553-

41.
57. Aviña-Zibeita JA, Esdaile JM.

Antimalarial medications. In:
Wallace DJ, Hajn BH, editors.

Dubois’ lupus erythematosus

and related syndroms. 8th ed.
Philadelphia: Elseview Saunders;

2013. P. 601-8.
58. Ruiz-Irastorza G, Ramos-Casals

M, Brito-Zeron P, Khamashta
CA. Clinical efficacy and side

effects of antimalarial in

systemic lupus erythematosus: A
systemic review. Ann Rheum Dis.

2010;69(1):20-8.
59. Marmor MF. Kellner U, Lai

TYY, MelSLE RB, Mieler WF,

Lum F. Recommendations on
screening for chloroquine and

hydroxychloroquine retinopathy
(2016 revision). Opthalmology.

2016;123(6);1386-94.

https://jfklin.rsupfatmawati.co.id/jfklin 50